J. Singh

发表

Expression of Core 2 β-1,6-N-Acetylglucosaminyltransferase in a Human Pancreatic Cancer Cell Line Results in Altered Expression of MUC1 Tumor-associated Epitopes*

M. Hollingsworth, P. Cheng, M. Burdick, 1999, The Journal of Biological Chemistry.

Comparison of the phosphorylation of microtubule-associated protein tau by non-proline dependent protein kinases

I. Grundke‐Iqbal, K. Iqbal, T. Singh, 1994, Molecular and Cellular Biochemistry.

EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival

J. Stein, D. Quinn, M. Buscarini, 2006, Oncogene.

Sequence specificity in the recognition of the epidermal growth factor receptor by the abl Src homology 2 domain.

D. Mcnamara, A. Saltiel, S. Decker, 1994, Oncogene.

Design of a potent peptide inhibitor of the epidermal growth factor receptor tyrosine kinase utilizing sequences based on the natural phosphorylation sites of phospholipase C-γ1

Juswinder Singh, D. W. Fry, A. McMichael, 1994, Peptides.

Comparison of conservation within and between the Ser/Thr and Tyr protein kinase family: proposed model for the catalytic domain of the epidermal growth factor receptor.

J. Singh, 1994, Protein engineering.

A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.

C. Q. Lin, J. Campisi, Y. Itahana, 2000, Cancer research.

Structure-based design of a potent, selective, and irreversible inhibitor of the catalytic domain of the erbB receptor subfamily of protein tyrosine kinases.

A Whitty, A. Whitty, D. W. Fry, 1997, Journal of medicinal chemistry.

Structural studies on the PH domains of Db1, Sos1, IRS-1, and beta ARK1 and their differential binding to G beta gamma subunits.

N. Thanki, C. Humblet, H. Levine, 1995, Biochemistry.

The receptor tyrosine kinase EphB4 is overexpressed in ovarian cancer, provides survival signals and predicts poor outcome

M. Deavers, L. Dubeau, N. Jennings, 2007, British Journal of Cancer.

Hydrophobic D-amino acids in the design of peptide ligands for the pp60src SH2 domain.

C. Humblet, E. Lunney, J. Marks, 1996, Drug design and discovery.